Comparative Pharmacology
Head-to-head clinical analysis: COLOCORT versus EMFLAZA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLOCORT versus EMFLAZA.
COLOCORT vs EMFLAZA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Colocort (hydrocortisone acetate) is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of inflammatory mediators such as prostaglandins and leukotrienes, and suppression of immune responses.
Agonist at glucocorticoid receptors, modulating gene expression to suppress inflammation and immune response.
10 mg rectally administered once daily, preferably at bedtime, as a retention enema.
0.6 mg/kg orally once daily (maximum 60 mg/day); titrate to lowest effective dose based on clinical response.
None Documented
None Documented
Terminal elimination half-life: 2.5–3.5 hours (mean ~3 hours). No active metabolites, so duration of action correlates with half-life.
6.2 hours (range 4.5–8.1 h) in healthy adults; prolonged in hepatic impairment.
Renal: ~30% as metabolites; fecal/biliary: ~20% as metabolites; remainder metabolized with minimal unchanged drug excreted.
Renal excretion of inactive metabolites; less than 5% excreted as unchanged drug in urine. Biliary/fecal elimination accounts for <1%.
Category C
Category C
Corticosteroid
Corticosteroid